Roivant Sciences Ltd.

16
Strong Sell
  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: BMG762791017
USD
29.05
0.56 (1.97%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Roivant Sciences Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
-264.00
-681.00
4,253.00
-1,224.00
-923.00
-898.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-621.00
-77.00
19.00
6.00
15.00
71.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-750.00
-839.00
-765.00
-843.00
-677.00
-552.00
Cash Flow from Investing Activities
-682.00
-1,766.00
5,203.00
-44.00
303.00
-31.00
Cash Flow from Financing Activities
134.00
-1,219.00
419.00
499.00
306.00
456.00
Net Cash Inflow / Outflow
-1,294.00
-3,824.00
4,858.00
-381.00
-67.00
-127.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
3.00
0.00
0.00
6.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Roivant Sciences Ltd.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
-264.578
62.383
-326.00
-524.12%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-621.796
-50.88
-571.00
-1122.08%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-750.349
117.417
-867.00
-739.05%
Cash Flow from Investing Activities
-682.333
-298.474
-384.00
-128.61%
Cash Flow from Financing Activities
134.236
-15.205
149.00
982.84%
Net Cash Inflow / Outflow
-1294.679
-191.334
-1,103.00
-576.66%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
3.767
4.928
-1.00
-23.56%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'26
stock-summary

YoY Growth in year ended Mar 2026 is 10.61% vs -9.69% in Mar 2025

Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
-750.35
-839.45
10.61%